Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09YVZ
|
|||
| Former ID |
DNC010423
|
|||
| Drug Name |
Benzaldehyde O-4-(heptyloxy)phenylcarbamoyl oxime
|
|||
| Synonyms |
CHEMBL597228; benzaldehyde O-4-(heptyloxy)phenylcarbamoyl oxime
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H26N2O3
|
|||
| Canonical SMILES |
CCCCCCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CC=CC=C2
|
|||
| InChI |
1S/C21H26N2O3/c1-2-3-4-5-9-16-25-20-14-12-19(13-15-20)23-21(24)26-22-17-18-10-7-6-8-11-18/h6-8,10-15,17H,2-5,9,16H2,1H3,(H,23,24)/b22-17+
|
|||
| InChIKey |
QGTJCMKYCHZBTK-OQKWZONESA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Oxime carbamate--discovery of a series of novel FAAH inhibitors. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1272-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.